Jun 13
|
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
|
Jun 9
|
OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
|
May 17
|
Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss
|
May 15
|
OPKO Health to Participate in Two Upcoming Investor Conferences
|
Apr 17
|
OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025
|
Apr 16
|
OPKO Health, Inc. (NASDAQ:OPK) boasts of bullish insider sentiment with 52% ownership and they have been buying lately
|
Mar 14
|
Tesla Stock Is Reaching a Breaking Point, Analyst Says. Plus, Vertical Aerospace, OPKO Health, and More.
|
Mar 14
|
Is OPKO Health, Inc. (OPK) The Best Stock Under $3 to Buy Now?
|
Mar 14
|
Labcorp is Set to Acquire Select Assets of BioReference Health of OPK
|
Mar 12
|
Labcorp to acquire certain assets of Opko Health’s BioReference Health
|
Mar 12
|
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’
|
Mar 11
|
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
|
Feb 13
|
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
|
Feb 12
|
Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy?
|
Oct 7
|
NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan
|
Oct 7
|
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
|
Sep 26
|
ENTX & OPK Stock May Gain Following Positive PK/PD Research Data
|
Sep 25
|
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
|
Sep 23
|
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
|
Jul 18
|
OPKO Health Announces $100 Million Share Repurchase Program
|